These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8159102)

  • 1. Diabetes increases hepatic hydroxymethyl glutaryl coenzyme A reductase protein and mRNA levels in the small intestine.
    Feingold KR; Wilson DE; Wood LC; Kwong LK; Moser AH; Grunfeld C
    Metabolism; 1994 Apr; 43(4):450-4. PubMed ID: 8159102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):407-11. PubMed ID: 15096652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
    Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
    J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diet influences hepatic hydroxymethyl glutaryl coenzyme A reductase and 7alpha-hydroxylase mRNA but not low-density lipoprotein receptor mRNA during development.
    Devlin AM; Innis SM; Shukin R; Rioux MF
    Metabolism; 1998 Jan; 47(1):20-6. PubMed ID: 9440472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
    Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
    J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and glucagon modulate hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by affecting immunoreactive protein levels.
    Ness GC; Zhao Z; Wiggins L
    J Biol Chem; 1994 Nov; 269(46):29168-72. PubMed ID: 7961882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase.
    Jurevics H; Hostettler J; Barrett C; Morell P; Toews AD
    J Lipid Res; 2000 Jul; 41(7):1048-54. PubMed ID: 10884284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic cholesterol biosynthesis by berberine during hyperhomocysteinemia.
    Wu N; Sarna LK; Siow YL; O K
    Am J Physiol Regul Integr Comp Physiol; 2011 Mar; 300(3):R635-43. PubMed ID: 21178122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compensatory responses to inhibition of hepatic squalene synthase.
    Lopez D; Chambers CM; Keller RK; Ness GC
    Arch Biochem Biophys; 1998 Mar; 351(2):159-66. PubMed ID: 9514656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for control of hydroxymethylglutaryl-coenzyme A reductase and cytochrome P-450 side chain cleavage message and enzyme in the corpus luteum.
    Puryear TK; McLean MP; Khan I; Gibori G
    Endocrinology; 1990 Jun; 126(6):2910-8. PubMed ID: 2351103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cutaneous permeability barrier disruption on HMG-CoA reductase, LDL receptor, and apolipoprotein E mRNA levels in the epidermis of hairless mice.
    Jackson SM; Wood LC; Lauer S; Taylor JM; Cooper AD; Elias PM; Feingold KR
    J Lipid Res; 1992 Sep; 33(9):1307-14. PubMed ID: 1402399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and hepatic cholesterogenesis in hypercholesterolemic dyslipidemia of experimental diabetes in dogs.
    Kwong LK; Feingold KR; Peric-Golia L; Le T; Karkas JD; Alberts AW; Wilson DE
    Diabetes; 1991 Dec; 40(12):1630-9. PubMed ID: 1756903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver.
    Powell EE; Kroon PA
    J Clin Invest; 1994 May; 93(5):2168-74. PubMed ID: 8182149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic HMG-CoA reductase expression and resistance to dietary cholesterol.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):412-6. PubMed ID: 15096653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total hydroxymethylglutaryl CoA reductase activity in the small intestine and liver of insulin-deficient rats.
    Young NL; Saudek CD; Crawford SA
    J Lipid Res; 1982 Feb; 23(2):266-75. PubMed ID: 7042879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing hyperphagia normalizes 3-hydroxy-3-methylglutaryl-CoA reductase activity in small intestine and liver of diabetic rats.
    Young NL; Saudek CD; Walters L; Lapeyrolerie J; Chang V
    J Lipid Res; 1982 Aug; 23(6):831-8. PubMed ID: 6957513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity.
    Ness GC; Chambers CM; Lopez D
    J Lipid Res; 1998 Jan; 39(1):75-84. PubMed ID: 9469588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin increases hepatic 3-hydroxy-methylglutaryl coenzyme A reductase mRNA and immunoreactive protein levels in diabetic rats.
    Ness GC; Wiggins L; Zhao Z
    Arch Biochem Biophys; 1994 Feb; 309(1):193-4. PubMed ID: 8117109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.